文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

丙戊酸治疗后的转录组变化促进神经发生并减轻继发性脑损伤

Transcriptomic changes following valproic acid treatment promote neurogenesis and minimize secondary brain injury.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论猪创伤性脑损伤合并失血性休克模型中,丙戊酸150 mg/kg减少脑 lesion 体积46%、减轻同侧脑水肿57%,并上调神经发生与促存活相关基因。

本研究在10头雌性猪中建立创伤性脑损伤合并失血性休克模型,随机分为生理盐水组(NS,3倍失血量)和NS+丙戊酸组(VPA 150 mg/kg),每组5头,观察6小时后取脑组织评估 lesion 体积、水肿并行RNA测序。VPA组脑 lesion 体积减少46%,同侧脑水肿减少57%。转录组分析显示VPA上调神经系统形态、神经元发育和神经元数量相关基因,下调凋亡、胶质细胞增殖和神经上皮细胞分化通路, Ingenuity Pathway Analysis 将VPA列为激活转录的首要上游调控因子,NEUROD1也显著上调。作者认为这些差异表达模式与VPA的神经发生和促存活效应一致。

要点

  • 在猪创伤性脑损伤合并失血性休克模型中,VPA 150 mg/kg使脑 lesion 体积减少46%、同侧脑水肿减少57%。
  • VPA上调神经系统形态、神经元发育和神经元数量相关基因,下调凋亡、胶质细胞增殖和神经上皮细胞分化通路。
  • Ingenuity Pathway Analysis 将VPA列为激活转录的首要上游调控因子,支持其直接导致这些转录变化。
  • 主转录调控因子NEUROD1也显著上调,提示VPA可能诱导额外转录因子。
  • 差异表达模式与VPA的神经发生和促存活效应一致,但机制尚未完全阐明。

适用人群与场景

  • 雌性猪创伤性脑损伤合并失血性休克模型,共10头,每组5头。

处置流程与药物剂量

  • 生理盐水组:给予3倍失血量的生理盐水;VPA组:在生理盐水基础上给予丙戊酸150 mg/kg。
  • 观察6小时后取脑组织评估 lesion 体积、水肿并进行RNA测序。

研究设计与关键结果

  • 研究类型:动物实验(猪创伤性脑损伤合并失血性休克模型),样本量10头,每组5头。
  • 干预与对照:生理盐水(3倍失血量) vs 生理盐水+丙戊酸150 mg/kg。
  • 主要终点:VPA组脑 lesion 体积减少46%,同侧脑水肿减少57%。
  • 转录组结果:VPA显著上调神经系统形态、神经元发育和神经元数量相关基因;下调凋亡、胶质细胞增殖和神经上皮细胞分化通路。
  • Ingenuity Pathway Analysis 将VPA列为激活转录的首要上游调控因子;NEUROD1显著上调。

证据类型、等级与局限

  • 证据类型:动物实验(猪模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为VPA治疗在伤后6小时内诱导了与神经发生和促存活效应一致的转录组变化,并减轻脑 lesion 体积和水肿。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Early treatment with valproic acid (VPA) has demonstrated benefit in preclinical models of traumatic brain injury, including smaller brain lesion size, decreased edema, reduced neurologic disability, and faster recovery. Mechanisms underlying these favorable outcomes are not fully understood. We hypothesized that VPA treatment would upregulate genes involved in cell survival and proliferation and downregulate those associated with cell death and the inflammatory response.

METHODS: Ten female swine were subjected to a protocol of traumatic brain injury and hemorrhagic shock. They were assigned to two groups (n = 5): normal saline (NS; 3× volume of shed blood), or NS + VPA (150 mg/kg). Following 6 hours of observation, brain tissue was harvested to evaluate lesion size and edema. Brain tissue was processed for RNA sequencing. Gene set enrichment and pathway analysis was performed to determine the differential gene expression patterns following injury.

RESULTS: Animals treated with VPA were noted to have a 46% reduction in brain lesion size and a 57% reduction in ipsilateral brain edema. Valproic acid significantly upregulated genes involved in morphology of the nervous system, neuronal development and neuron quantity. The VPA treatment downregulated pathways related to apoptosis, glial cell proliferation, and neuroepithelial cell differentiation. Ingenuity Pathway Analysis identified VPA as the top upstream regulator of activated transcription, supporting it as a direct cause of these transcriptional changes. Master transcriptional regulator NEUROD1 was also significantly upregulated, suggesting that VPA may induce additional transcription factors.

CONCLUSION: Administration of VPA attenuated brain lesion size, reduced brain edema, and induced significant changes in the transcriptome of injured brain within 6 hours. Patterns of differential expression were consistent with the proposed neurogenic and prosurvival effects of VPA treatment.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Nikolian VC, Dennahy IS, Higgins GA, et al. Transcriptomic changes following valproic acid treatment promote neurogenesis and minimize secondary brain injury. J Trauma Acute Care Surg. 2018. PMID: 29251707. doi:10.1097/TA.0000000000001765

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。